
Oncology Nursing 101 - (On-Demand) 2026
Oncology Nursing 101: A Hematology & Oncology Primer for Nurses (On-Demand) 2026
To help nurses prepare for a new career in the specialty of oncology, Horizon CME has developed “Oncology Nursing 101: A Hematology and Oncology Primer for Nurses”. This on-demand program is an engaging, foundational program designed to help new oncology nurses build confidence and clinical competence.
The course covers cancer basics, treatment modalities, symptom management, oncologic emergencies, survivorship, and the human side of care. Through case-based learning participants will gain practical insight and a stronger foundation for delivering safe, compassionate oncology care.
Learning Objectives
- Describe mechanisms of action, therapeutic uses, and key adverse effects of emerging cancer therapies relevant to oncology nursing practice.
- Recognize the role of biomarkers, molecular testing, and precision diagnostics in guiding treatment planning and patient education.
- Identify common toxicities, complications, and symptom management strategies associated with cancer therapies.
- Apply principles of safe medication administration, monitoring, and patient safety in the delivery of oncology treatments.
- Explain the roles of multidisciplinary team members and the nurse’s role in coordinating comprehensive cancer care.
- Discuss patient-centered supportive care strategies, including fertility preservation, sexual health, psychosocial support, and survivorship considerations.
- Summarize recent advances in oncology treatment and their implications for nursing care and patient outcomes.
This activity is intended for new oncology nurses, RN's needing a refresher, NPs, CNAs and other healthcare providers involved in the care of cancer patients.

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners
Laura Johnson, DNP, MSN, APRN, AGCNS-BC, BMTCN discloses Advisory Board with Sanofi but this relationship has ended during the past 24 months.
Jennifer S. Webster, DNP, MPH, RN, AOCNS discloses Consulting fees and Speaker’s Bureau with G1 Therapeutics (no longer in business but this relationship has ended, Consulting fees and Speaker’s Bureau with Amgen and Speaker’s Bureau with Bristol Myers Squibb and during the past 24 months.
*Horizon CME has mitigated and resolved all relevant financial relationships
Faculty
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Consulting fees with Janssen, Sanofi, GSK during the past 24 months.
Emily M. Beard, RN, OCN, CBCN, BHCN discloses the following Consultant for content development for patient education with Amplity for Eli Lilly, Speaker for video series for patient education project with Amplity for Tera Sera Therapeutics and Nurse Navigator advisory board for education development with Amplity for Relay Therapeutics but these relationships have ended during the past 24 months.
Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors
All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.
Available Credit
- 15.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Enduring activity for a maximum of 15.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 15.00 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 15.00 credit.
- 1.75 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 1.75 credit.
Price
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Facebook
X
LinkedIn
Forward